SCARA3 and obesity due to melanocortin 4 receptor deficiency: Together, the present study combining bioinformatic analysis with the several biochemical functional analyses in vitro and in vivo, provided strong supports for the hypothesis that SCARA3 is a potential target for the treatment of obesity and other metabolic disorders.